Over the last 50 years, botulinum toxin has been transformed from a cause of life-threatening disease to an effective medical therapy.
It has been used in a variety of specialties for different indications, significantly improving patient quality of life. A recent growing body of evidence suggests that intra-detrusor injection of botulinum toxin may have beneficial effects in patients with medication refractory detrusor overactivity and may offer a new minimally invasive alternative to patients with severe overactive bladder symptoms. To review current data regarding the effects of botulinum toxin in patients with overactive bladder, a MEDLINE(®)/PubMed(®) literature search was carried out. The mechanism of action, clinical usage, adverse effects, and treatment efficacy were reviewed and the results are presented in this paper.
Written by:
Orasanu B, Mahajan ST. Are you the author?
Departments of Urology and Obstetrics and Gynecology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Reference: Indian J Urol. 2013 Jan;29(1):2-11.
doi: 10.4103/0970-1591.109975
PubMed Abstract
PMID: 23671356
UroToday.com Overactive Bladder (OAB) Section
